The history of Alzheimer's disease

Alzheimer's disease is a terrible problem that has been affecting those old in age for centuries. Most of the knowledge that we have about the affliction, we've learned within the past one hundred years. In this article, we'll give you a brief history of our knowledge of the disease, letting you know where our basic understandings of the disease came from and some of the advances that are being made today.

Alzheimer's disease was first discovered by a German doctor named Alois Alzheimer. The doctor discovered the disease when he was performing an autopsy on a woman who died of a mysterious, unknown form of mental illness. When Alzheimer studied the brain of the woman, he was shocked to find the presence of abnormal lumps of plaque and twisted fibers present in her brain that were unlike anything he'd ever seen before. These two odd parts of the woman's anatomy proved to be the basis for Alzheimer's disease, with the lumps becoming known as neuritic plaques and the fibers being called neurofibrillary tangles. To this day, the presence of these lumps and fibers are the way that doctors can confirm the presence of Alzheimer's disease. Unfortunately, these symptoms can only be seen via an autopsy performed after a patient's death.

One discovery that changed our knowledge of Alzheimer's disease is when Familial Alzheimer's disease was discovered. This subset of the disease occurs in approximately 10 percent of all patients with Alzheimer's, and it is a particularly aggressive form of the disease. It occurs early in almost every case, with most becoming afflicted with the disease before the age of 65. One of the most unfortunate aspects of Familial Alzheimer's disease is the fact that it can be passed down genetically from parent to child. If one parent has Familial Alzheimer's, the child's risk of getting the disease rests at an even 50-50. Familial Alzheimer's is the only type of the disease that can be traced to a genetic abnormality; late-onset Alzheimer's may appear randomly and without just cause.

1993 saw one of the first significant developments in fighting Alzheimer's disease. In this year, the Food and Drug Administration of the United States of America gave approval to the first drug designed to help Alzheimer's patients. Known as Cognex, the pill worked to increase the amount of acetylcholine in the brain, which is a neurotransmitter that can help to slow the mind-damaging aspects of the disease. Within the next few years, 3 more drugs came out in order to increase acetylcholine levels in Alzheimer's patients. In 1997, scientists discovered that the use of Vitamin E and a Parkinson's disease drug known as Eldepryl were shown to be effective in slowing the mental decline of Alzheimer's patients, offering another solution when it comes to slowing the disease. The latest advancement came in 2003 when the FDA approved a radically different drug that is known as Namenda. It is used in order to protect the brain cells of an Alzheimer's patient by blocking the amount of Glutamine that is present in the brain, which can damage the cells.

More and more research is being conducted when it comes to finding possible solutions for those with Alzheimer's, and hopefully, the advancements that are being made will continue to help those with this devastating disease.

Alzheimer's Disease on the Web

Can We Cure Alzheimer's Disease? - Huffington Post (blog)

New York Times

Can We Cure Alzheimer's Disease?
Huffington Post (blog)
Age is the single greatest risk factor for getting Alzheimer's disease, which has become a worldwide epidemic. More than 5 million Americans are already afflicted, and every 70 seconds another is diagnosed. As 80 million baby boomers begin reaching age ...
Path Is Found for the Spread of Alzheimer'sNew York Times
How Alzheimer's spread in brainDaily News & Analysis
Study Tracks Alzheimer's Progression In MiceNPR
Toronto Star -CBS News -TruthDive
all 224 news articles »

Take the Alzheimer's test: The 21 questions that can reveal if YOU are at risk... - Daily Mail

CBC.ca

Take the Alzheimer's test: The 21 questions that can reveal if YOU are at risk...
Daily Mail
By Fiona Macrae A quick test that tells if your loved one is at risk of Alzheimer's disease has been devised by doctors. The 21-question test distinguishes between normal absent-mindedness and the more sinister memory lapses that may signal the early ...
Senior Moment or Something Worse? Yes/No Test May TellWebMD
Is your loved one just forgetful or at risk of Alzheimer's disease?CBC.ca
Alzheimer's Disease Video: How to Tell the Difference Between Alzheimer's ...Insidermedicine
eMaxHealth -Science Codex -ABC Action News
all 54 news articles »

Clients with Alzheimer's pose 'scary' legal risks - InvestmentNews

Clients with Alzheimer's pose 'scary' legal risks
InvestmentNews
By Andrew Osterland It's not an easy conversation to have, but financial advisers need to talk to their clients about Alzheimer's disease and other forms of dementia and the impact it can have on their financial circumstances.
Guest opinion: US needs leadership to battle Alzheimer's diseaseBillings Gazette

all 2 news articles »

Lilly Alzheimer's drug an unlikely ace in the hole - Reuters

Lilly Alzheimer's drug an unlikely ace in the hole
Reuters
By Ransdell Pierson | NEW YORK (Reuters) - A treatment for Alzheimer's disease is the drug industry's longest shot, and any brave investors willing to place a bet on the outcome are likely to focus on Eli Lilly & Co. Lilly and Pfizer Inc are the ...
Is Lilly betting the farm on its high-stakes Alzheimer's gamble?FierceBiotech

all 13 news articles »

Nobel winner joins Lou Ruvo Center - Las Vegas Review - Journal

Nobel winner joins Lou Ruvo Center
Las Vegas Review - Journal
Ruvo, a philanthropist whose passion for finding a cure for Alzheimer's disease has been recognized by top health officials around the world, said he is confident that the association of the 69-year-old Prusiner with the Ruvo Center will bring more top ...

and more »

Check out book to help prevent Alzheimer's disease - Lancaster Eagle Gazette

Check out book to help prevent Alzheimer's disease
Lancaster Eagle Gazette
Most people think there is little or nothing they can do to avoid Alzheimer's. But prominent researchers now say our best and perhaps only hope of defeating Alzheimer's is to prevent it. Author Jean Carper, a graduate of Ohio Wesleyn University, ...

FDA clearance of Alzheimer's disease drug trials and Interviews Taj Pharma ... - India PRwire (press release)

India PRwire (press release)

FDA clearance of Alzheimer's disease drug trials and Interviews Taj Pharma ...
India PRwire (press release)
The interview, which was published on TF1 and BBC, focuses on Taj Pharma's UK launch of its Alzheimer's disease drug, Gabapentin, and the company's growth strategies. Mumbai, Maharashtra, February 4, 2012 /India PRwire/ -- Taj Pharma Group., ...

Howe raising awareness of dementia while feeling its effects - TSN

CBC.ca

Howe raising awareness of dementia while feeling its effects
TSN
They did that with Colleen, who died at 76 of Pick's disease. Pick's is a rare form of dementia marked by changes in mood, behaviour and personality, followed by memory loss similar to that experienced in Alzheimer's. Gordie's dementia is currently ...
Gordie Howe's Health Causing Widespread SpeculationTechnorati
Mr. Hockey makes Buble bubblyCastanet.net
NHL: Red Wing Legend Gordie Howe Does Not Have Dementia, Says Son.Bleacher Report
New York Times
all 359 news articles »

Why 2 new studies represent important breakthrough in Alzheimer's disease research - Science Codex

Why 2 new studies represent important breakthrough in Alzheimer's disease research
Science Codex
Clarksburg, MD—Two different research groups have independently made the same important discoveries on how Alzheimer's disease spreads in the brain, according to a February 2 New York Times story. The groups' findings have the potential to give us a ...

Mother of NASCAR driver Matt Kenseth dies at age 63 after battling Alzheimer's ... - Washington Post

Mother of NASCAR driver Matt Kenseth dies at age 63 after battling Alzheimer's ...
Washington Post
An obituary from a Cambridge, Wis., funeral home and Kenseth's fan website say Nicola “Nicki” Sue Kenseth battled Alzheimer's disease and died Tuesday at age 63 at Oak Park Place in Cottage Grove. Matt Kenseth grew up in Cambridge and won the Daytona ...
Mother of NASCAR driver Matt Kenseth passesExaminer.com

all 142 news articles »


Google News